Four-axis fecal metabolome alterations and an exploratory 5-metabolite signature for detecting subjective cognitive decline across the clinically defined Alzheimer's disease spectrum
The gut-brain axis is implicated in Alzheimer's disease (AD), but fecal metabolomic changes across the healthy controls (HC)→subjective cognitive decline (SCD)→mild cognitive impairment (MCI)→AD clinical spectrum, especially at the SCD stage, remain poorly characterized. Without amyloid/tau confirmation, our groups...